Survival after HIV infection stage 3 (AIDS) diagnosis, by population density areas, United States, 2005-2010

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: We examined the survival rates after diagnosis of HIV infection stage 3 (AIDS) in the United States by population density area of residence at diagnosis. Methods: We used data from the National HIV Surveillance System to calculate survival rates among people aged ≥13 with HIV infection stage 3 (AIDS) diagnosed from 2005 through 2010. We determined survival rates for more than 12, 24, and 36 months after diagnosis; overall and by demographic characteristics; and across 3 population density area categories (large metropolitan statistical areas [MSAs, ≥500 000 people], small-to-medium MSAs [50 000 to 499 999 people], and nonmetropolitan areas [<50 000 people]). Results: The survival rates for more than 12, 24, and 36 months after diagnosis were highest among people residing in large MSAs (90.2%, 87.2%, and 84.9%, respectively) and lowest among people residing in nonmetropolitan areas (87.3%, 84.1%, and 81.4%, respectively). With a few exceptions, survival rates were lower in those residing in nonmetropolitan areas than those residing in large MSAs and small-to-medium MSAs across most subgroups by age at diagnosis, race/ethnicity, sex, transmission category, region of residence, and year of diagnosis. Between 2005 and 2010, significant year-to-year increases occurred in the proportion of people surviving more than 36 months after diagnosis across all 3 population density area categories (estimated annual percentage change: large MSAs [0.88; 95% confidence interval (CI), 0.56-1.20]; small-to-medium MSAs [0.94; 95% CI, 0.06-1.83]; and nonmetropolitan areas [1.26; 95% CI, 0.07-2.46]). Conclusions: Although survival rates for those with HIV infection stage 3 (AIDS) improved in all 3 population density area categories, efforts to remove barriers to care and promote treatment adherence in nonmetropolitan areas will be necessary to eliminate survival disparities.

References Powered by Scopus

Retention in care: A challenge to survival with HIV infection

473Citations
N/AReaders
Get full text

'Triply cursed': Racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black gay men

303Citations
N/AReaders
Get full text

Barriers to care among persons living with HIV/AIDS in urban and rural areas

237Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Trends in State Policy Support for Sexual Minorities and HIV-Related Outcomes Among Men Who Have Sex With Men in the United States, 2008-2014

17Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bosh, K. A., Shi, J., & Chen, M. (2017). Survival after HIV infection stage 3 (AIDS) diagnosis, by population density areas, United States, 2005-2010. Public Health Reports, 132(5), 570–578. https://doi.org/10.1177/0033354917722143

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

82%

Professor / Associate Prof. 1

9%

Researcher 1

9%

Readers' Discipline

Tooltip

Nursing and Health Professions 5

50%

Medicine and Dentistry 3

30%

Pharmacology, Toxicology and Pharmaceut... 1

10%

Social Sciences 1

10%

Save time finding and organizing research with Mendeley

Sign up for free